The role of PET in a clinically silent and ultrasound negative synovitis in the course of rheumatoid arthritis - a case report
Submitted: 23 September 2019
Accepted: 19 February 2021
Published: 19 April 2021
Accepted: 19 February 2021
Abstract Views: 3208
PDF: 425
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Similar Articles
- R. Herrera-Esparza, E. Avalos-Diaz, Infliximab treatment in a case of rheumatoid scleromalacia perforans , Reumatismo: Vol. 61 No. 3 (2009)
- M. Gutierrez, E. Filippucci, L. Bugatti, C. Bertolazzi, W. Grassi, Severe drug hypersensitivity syndrome due to sulphasalazine in patient with rheumatoid arthritis , Reumatismo: Vol. 61 No. 1 (2009)
- P. Sarzi- Puttini, M. Antivalle, A. Marchesoni, E.G. Favalli, R. Gorla, M. Filippini, R. Caporali, F. Bobbio-Pallavicini, C. Montecucco, F. Atzeni, Efficacy and safety of anti-TNF agents in the Lombardy rheumatoid arthritis network (LORHEN) , Reumatismo: Vol. 60 No. 4 (2008)
- R. Scrivo, F. Conti, F.R. Spinelli, S. Truglia, L. Magrini, M. Di Franco, F. Ceccarelli, G. Valesini, Switching between TNFα antagonists in rheumatoid arthritis: personal experience and review of the literature , Reumatismo: Vol. 61 No. 2 (2009)
- E. Bartoloni Bocci, S. Marchesi, F. Delle Monache, G. Vaudo, A. Giordano, F. Ragni Alunni, C. Angrisani, E. Mannarino, Y. Shoenfeld, R. Gerli, Subclinical atherosclerosis in young patients with rheumatoid arthritis and low disease activity , Reumatismo: Vol. 57 No. 1 (2005)
- P. Caramaschi, S. Pieropan, A. Volpe, A. Carletto, L.M Bambara, D. Biasi, Sustained response to infliximab treatment in two cases of early rheumatoid arthritis that has been maintained after drug withdrawal , Reumatismo: Vol. 60 No. 3 (2008)
- M. Carotti, F. Salaffi, M. Mangiacotti, A. Cerioni, G.M. Giuseppetti, W. Grassi, Atherosclerosis in rheumatoid arthtritis: the role of high-resolution B mode ultrasound in the measurement of the arterial intima-media thickness , Reumatismo: Vol. 59 No. 1 (2007)
- G. Arioli, S. Maddali Bongi, N. Pappone, The rehabilitative approach in rheumatoid arthritis , Reumatismo: Vol. 60 No. 4 (2008)
- A.R. Giardina, A. Accardo-Palumbo, F. Ciccia, A. Ferrante, A. Principato, R. Impastato, G. Triolo, Blocking TNF in vitro with infliximab determines the inhibition of expansion and interferon gamma production of Vγ9/Vδ2 T lymphocytes from patients with active rheumatoid arthritis. A role in the susceptibility to tuberculosis? , Reumatismo: Vol. 61 No. 1 (2009)
- A. Iagnocco, C. Perella, F. Ceccarelli, E. Tripodo, C. Alessandri, L. Magrini, G. Valesini, Ultrasonographic assessment of the response to Etanercept treatment in patients with rheumatoid arthritis , Reumatismo: Vol. 58 No. 3 (2006)
<< < 17 18 19 20 21 22 23 24 25 26 > >>
You may also start an advanced similarity search for this article.